DR US

The chart shows the growth of an initial investment of $10,000 in DR US, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

As of Apr 2, 2026, the DR US returned -2.46% Year-To-Date and 14.07% of annualized return in the last 10 years.

Based on dividend-adjusted daily data since Jul 3, 2014, DR US's average daily return is +0.05%, while the average monthly return is +1.08%. At this rate, your investment would double in approximately 5.4 years.

Historically, 68% of months were positive and 32% were negative. The best month was Apr 2020 with a return of +12.3%, while the worst month was Mar 2020 at -11.6%. The longest winning streak lasted 15 consecutive months, and the longest losing streak was 3 months.

On a daily basis, DR US closed higher 56% of trading days. The best single day was Apr 1, 2026 with a return of +10.3%, while the worst single day was Mar 12, 2020 at -9.0%.

DR US has an annualized alpha of 5.27%, beta of 0.67, and R² of 0.52 versus S&P 500 Index. Calculated based on daily prices since July 03, 2014.

• This portfolio captured 104.22% of S&P 500 Index gains but only 96.98% of its losses — a favorable profile for investors.
• This portfolio generated an annualized alpha of 5.27% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.
• Beta of 0.67 indicates this portfolio moves significantly less than S&P 500 Index — a genuinely defensive profile with reduced participation in both market rallies and downturns.

DR US has an expense ratio of 0.26%, which is considered low. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

DR US ranks 66 for risk / return — better than 66% of portfolios on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

DR US Sharpe ratios as of Apr 2, 2026 (values are recalculated daily):

• 1-Year: 0.96
• 5-Year: 0.59
• 10-Year: 0.84
• All Time: 0.76

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 1.00 to 1.69, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of DR US compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

DR US provided a 0.61% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the DR US. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the DR US was 33.43%, occurring on Mar 23, 2020. Recovery took 93 trading sessions.

The current DR US drawdown is 5.51%.

The chart below shows the rolling one-month volatility.